Sold as Darvocet. Every FDA application for this active ingredient: 1 branded and 7 generic.
As of Nov 16, 2026, FDA lists 8 applications for Acetaminophen; Propoxyphene Hydrochloride (sold as Darvocet), first approved Oct 18, 1972, with 0 new uses approved and 0 published complete response letters.
| Oct 18, 1972 | DarvocetNDA 16844 · New combination | Aaipharma LLC | 0 | Discontinued |
| Oct 25, 1974 | Propoxyphene Hydrochloride And AcetaminophenANDA 83689 | Mylan | 0 | Discontinued |
| Oct 25, 1974 | Propoxyphene Hydrochloride And AcetaminophenANDA 83978 | Mylan | 13 | Discontinued |
| Sep 3, 1976 | WygesicANDA 84999 | Caraco | 8 | Discontinued |
| Jul 18, 1989 | Propoxyphene Hydrochloride And AcetaminophenANDA 89959 | Sandoz | 8 | Discontinued |
| Dec 16, 1996 | Propoxyphene Hydrochloride And AcetaminophenANDA 40139 | Watson Labs | 6 | Discontinued |
| Jul 30, 2003 | Propoxyphene Hydrochloride And AcetaminophenANDA 40507 | Vintage Pharms | 0 | Discontinued |
| — | Dolene Ap-65ANDA 85100 | Lederle | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA